Calamos Wealth Management LLC cut its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 6.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 91,890 shares of the enterprise software provider's stock after selling 6,057 shares during the quarter. Calamos Wealth Management LLC's holdings in Oracle were worth $12,847,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Sunbeam Capital Management LLC bought a new position in Oracle in the fourth quarter worth approximately $30,000. Hurley Capital LLC bought a new position in shares of Oracle in the 4th quarter worth $33,000. Redmont Wealth Advisors LLC bought a new position in shares of Oracle in the 1st quarter worth $27,000. Inlight Wealth Management LLC bought a new position in shares of Oracle in the 1st quarter worth $28,000. Finally, Synergy Investment Management LLC bought a new position in shares of Oracle in the fourth quarter valued at $34,000. 42.44% of the stock is owned by institutional investors.
Oracle Stock Performance
Shares of ORCL traded up $7.41 during mid-day trading on Friday, hitting $237.39. The stock had a trading volume of 18,441,376 shares, compared to its average volume of 10,159,668. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $237.99. The business has a fifty day moving average price of $178.14 and a 200-day moving average price of $164.25. The firm has a market cap of $666.79 billion, a P/E ratio of 54.70, a PEG ratio of 3.55 and a beta of 1.39. The company has a debt-to-equity ratio of 4.07, a current ratio of 0.75 and a quick ratio of 0.75.
Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.06. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The business had revenue of $15.90 billion for the quarter, compared to analysts' expectations of $15.58 billion. During the same period in the previous year, the business posted $1.63 EPS. The firm's quarterly revenue was up 11.3% compared to the same quarter last year. On average, equities research analysts expect that Oracle Corporation will post 5 EPS for the current year.
Oracle Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 24th. Investors of record on Thursday, July 10th will be paid a dividend of $0.50 per share. The ex-dividend date is Thursday, July 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.84%. Oracle's payout ratio is 46.08%.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on ORCL. Oppenheimer reaffirmed an "outperform" rating on shares of Oracle in a research note on Wednesday, June 18th. BMO Capital Markets raised their price target on shares of Oracle from $235.00 to $245.00 and gave the company an "outperform" rating in a research report on Wednesday. Royal Bank Of Canada raised their target price on Oracle from $145.00 to $195.00 and gave the company a "sector perform" rating in a report on Thursday, June 12th. Stephens assumed coverage on Oracle in a report on Wednesday, March 19th. They issued an "equal weight" rating and a $167.00 target price on the stock. Finally, JPMorgan Chase & Co. raised their target price on Oracle from $135.00 to $185.00 and gave the company a "neutral" rating in a report on Thursday, June 12th. Ten research analysts have rated the stock with a hold rating, twenty-two have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $204.15.
Read Our Latest Stock Analysis on ORCL
Insider Buying and Selling
In other news, Director Leon E. Panetta sold 17,500 shares of the company's stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $151.24, for a total transaction of $2,646,700.00. Following the sale, the director directly owned 58,090 shares in the company, valued at $8,785,531.60. This represents a 23.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Vice Chairman Jeffrey Henley sold 400,000 shares of the company's stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $190.42, for a total value of $76,168,000.00. Following the sale, the insider owned 1,097,576 shares in the company, valued at approximately $209,000,421.92. This represents a 26.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 440,366 shares of company stock valued at $83,103,603. 42.20% of the stock is owned by company insiders.
About Oracle
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.